logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Shuang-Jian Qiu

fudan university
H指数:55
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Adjuvant camrelizumab combined with capecitabine in patients with intrahepatic cholangiocarcinoma after surgical resection in China (ACC): a single-arm, single-centre, open-label, phase 2 trial

中国患者术后肝内胆管癌的辅助性卡瑞利珠单抗联合卡培他滨治疗（ACC）：一项单臂、单中心、开放标签、II期临床试验

The Lancet Gastroenterology & Hepatology
IF38.6
2025-11-270
PRE
Zheng Wang; Lixing Li; Peiran Huang; Honghu Tu; Xiangyu Zhang; Lei Yu; Fei Liang; Cheng Huang; Shuangjian Qiu; Qinghai Ye; Zhenbin Ding; Xiaowu Huang; Yinghong Shi; Kang Song; Huichuan Sun; Xiaoying Wang; Yongfeng Xu; Yao Yu; Qiang Gao; Lan Zhang
First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study

一线tislelizumab和ociperlimab联合吉西他滨和顺铂治疗晚期胆道癌 (zsab-top): 一项多中心，单臂，2期研究

Signal Transduction and Targeted Therapy
IF52.7
2025-08-210
OAAI
Guoming Shi; Xiaoyong Huang; Liang Ma; Hui Li; Jianhong Zhong; Junye Wang; Qiang Gao; Xiaojun Guo; Shuangjian Qiu; Huichuan Sun; Yinghong Shi; Xiaowu Huang; Xiaoying Wang; Yong Yi; Xiaodong Zhu; Cheng Huang; Zhenbin Ding; Yi Chen; Yifeng He; Yinghao Shen; Qiman Sun; Jian Zhou; Jia Fan
Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study

Lenvatinib联合anti-PD-1治疗对最初不可切除的肝细胞癌患者是一种可行的转换切除策略: 一项回顾性研究

FRONTIERS IN ONCOLOGY
IF3.3
2022-11-2426
OAAI
Yi, Yong; Sun, Bao-Ye; Weng, Jia-Lei; Zhou, Cheng; Zhou, Chen-Hao; Cai, Ming-Hao; Zhang, Jing-Yun; Gao, Hong; Sun, Jian; Zhou, Jian; Fan, Jia; Ren, Ning; Qiu, Shuang-Jian

研究方向

暂未获取到该数据
樊
樊嘉
H 指数:126论文数:1,507被引数:6.8万
周
周箭
H 指数:104论文数:1,031被引数:4.6万
Y
Ying‐Hong Shi
H 指数:56论文数:345被引数:1.5万
高
高强
H 指数:74论文数:498被引数:2.0万
Y
Yong Yi
H 指数:29论文数:110被引数:2,522
Z
Zhen‐Bin Ding
H 指数:43论文数:190被引数:6,199
孙
孙会
H 指数:74论文数:540被引数:2.1万
X
Xin‐Rong Yang
H 指数:58论文数:256被引数:1.5万
Z
Zhi Dai
H 指数:46论文数:175被引数:8,428
J
Jian Zhou
H 指数:59论文数:476被引数:1.4万